For the Inventor, By the Inventor

Enter assignee name

Ganymed Pharmaceuticals Gmbh

USPTO Granted Patents = 10

CIPO Patents = 6

EPO Patents = 20

Forward Citations = 15

Loading Chart...

Loading Chart...

66 inventors (with patents filed for the assignee):

Ugur Sahin (10 out of 182 patents)

Korden Walter (6 out of 18 patents)

Michael Koslowski (6 out of 53 patents)

4. Özlem Türeci (5 out of 52 patents)

5. Stefan Woll (5 out of 15 patents)

6. Maria Kreuzberg (5 out of 15 patents)

7. Bernd Hubner (4 out of 8 patents)

8. Michael Erdeljan (4 out of 8 patents)

9. Ozlem Tureci (3 out of 53 patents)

10. Michael Weichel (2 out of 4 patents)

11. Dirk Usener (2 out of 19 patents)

12. Stefan Fritz (2 out of 9 patents)

13. Christoph Uherek (2 out of 7 patents)

14. Gunda Brandenburg (2 out of 9 patents)

15. Harald-Gerhard Geppert (2 out of 10 patents)

10 patents: Sort by Forward Citations

1. 11859008 - Antibodies for treatment of cancer expressing claudin 6 (2024-01-02),

2. 11858988 - Antibodies specific for claudin 6 (CLDN6) (2024-01-02),

3. 11473085 - Methods and compositions for diagnosis and treatment of cancer (2022-10-18),

4. 10919974 - Antibodies for treatment of cancer expressing claudin 6 (2021-02-16),

5. 10844133 - Cancer therapy using CLDN6 target-directed antibodies in vivo (2020-11-24),

6. 10745477 - Antibodies specific for claudin 6 (CLDN6) (2020-08-18),

7. 10717780 - Agents for treatment of claudin expressing cancer diseases (2020-07-21),

8. 10174104 - Monoclonal antibodies against claudin-18 for treatment of cancer (2019-01-08),

9. 10137195 - Therapy involving antibodies against Claudin 18.2 for treatment of cancer (2018-11-27),

10. 10017564 - Monoclonal antibodies against claudin-18 for treatment of cancer (2018-07-10),

Ganymed Pharmaceuticals GmbH is a biopharmaceutical company dedicated to the development of innovative cancer therapeutics. With a focus on precision medicine, Ganymed aims to provide targeted treatment options for patients with unmet medical needs. The company's pipeline includes novel antibody-drug conjugates and immunotherapies designed to improve outcomes for cancer patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

10 Patents

#20 in Mainz

#3,713 in Germany

#54,238 in the World

Ganymed Pharmaceuticals Gmbh

Forward Citations = 15

66 inventors:

Ugur Sahin (10 out of 182 patents)

Korden Walter (6 out of 18 patents)

Michael Koslowski (6 out of 53 patents)

4. Özlem Türeci (5 out of 52 patents)

5. Stefan Woll (5 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…